Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 128Brain Neoplasms 114Prostatic Neoplasms 101Neoplasm Metastasis 83Lung Neoplasms 71Carcinoma, Hepatocellular 71Pancreatic Neoplasms 67Breast Neoplasms 47Melanoma 44Carcinoma, Renal Cell 36Neoplasms 33Colorectal Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Glioblastoma 24Liver Neoplasms 20Head and Neck Neoplasms 16Small Cell Lung Carcinoma 15Sarcoma 13Glioma 12Kidney Neoplasms 11Urinary Bladder Neoplasms 9Recurrence 9Gliosarcoma 8Ovarian Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma 7Prostate Cancer Metastatic 6Cholangiocarcinoma 6Central Nervous System Neoplasms 6Uveal Melanoma 5

Interventions

Docetaxel 4pembrolizumab 3Pemetrexed 3Nivolumab 2Cisplatin 2Carboplatin 2tislelizumab 1rofecoxib 1paclitaxel poliglumex 1osimertinib 1nazartinib 1lenvatinib 1aumolertinib 1atezolizumab 1anlotinib 1aflutinib 1abivertinib 1Rosuvastatin Calcium 1Radiosurgery 1RO5126766 1Platinum Compounds 1Midazolam 1Gemcitabine 1Gefitinib 1Food 1Esomeprazole 1Drug Therapy 1Dabigatran 1Bevacizumab 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Non-small Cell Lung Cancer × Radiosurgery × Clear all
NCT03727867 2019-01-30

Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer

Taizhou Hospital

Phase 3 Unknown
300 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡